TG Therapeutics, Inc.
NASDAQ:TGTX · NASDAQ Capital Market
+$1.03 today
Vol 7.15M · Avg 2.15M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+45.57%
Period High
$53.22
Period Low
$26.39
Latest
$53.22
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Arrowhead Pharmaceuticals, Inc.
NASDAQ:ARWR
$11.88B
Krystal Biotech, Inc.
NASDAQ:KRYS
$10.33B
Alkermes plc
NASDAQ:ALKS
$7.56B
Vaxcyte, Inc.
NASDAQ:PCVX
$7.51B
Kymera Therapeutics, Inc.
NASDAQ:KYMR
$7.47B
Immunovant, Inc.
NASDAQ:IMVT
$7.30B
Protagonist Therapeutics, Inc.
NASDAQ:PTGX
$7.27B
Arcellx, Inc.
ACLX
$6.73B
PTC Therapeutics, Inc.
NASDAQ:PTCT
$6.57B
CRISPR Therapeutics AG
NASDAQ:CRSP
$5.36B
What is the latest TGTX filing?
The latest filing shown is 4 dated Jun 15, 2026.
How many recent filings does TGTX have?
Intrinsic Alpha currently shows 20 recent filings for TGTX.
Explore More
Continue the stock analysis
Jump to another research area for this company.